ArticleMolecular oncology2022

Pre- and post-treatment blood-based genomic landscape of patients with ROS1 or NTRK fusion-positive solid tumours treated with entrectinib.

Rafal Dziadziuszko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.